AVOQ, LLC for PFIZER, INC.
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 1st Quarter - Report | Apr 22, 2024 | $50,000 | Replaced |
| 1st Quarter - Amendment (this page) | Sep 17, 2024 | $50,000 | Yes |
What was lobbied
3 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
General health issues; H.R. 4307/S. 2115, Medical Supply Chain Resiliency Act; H.R. 7174, To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| SANDRA ALCALA | — |
| STEVEN ELMENDORF | — |
| BILL GHENT | — |
Trade (domestic/foreign) TRD
Issues related to a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver for COVID-19 therapeutics
| Lobbyist | Covered position, as disclosed |
|---|---|
| SANDRA ALCALA | — |
| STEVEN ELMENDORF | — |
| BILL GHENT | — |
Taxation/Internal Revenue Code TAX
Issues related to the Vaccine Injury Compensation Program
| Lobbyist | Covered position, as disclosed |
|---|---|
| BILL GHENT | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.